Insider Selling at Pfizer (PFE) is Significant

Tuesday, August 08, 2017 10:15 PM ET

Insider Selling at Pfizer (PFE) is Significant

A SEC filing today revealed a significant insider sale of Pfizer shares as — Ian C Read, Director and Officer — sold 96,950 shares in the company having a market value of approximately $3,296,300. This is the first insider buy/sell trade in the past 90 days.

Pfizer buy-sell trading activity is close to the 108 member peer company average. The Pharmaceuticals peer group saw 105 buy/sell trades during this period for an average of 1.0 transactions per company. However, trading at Pfizer represents a lower number of shares per transaction. Within the peer group there were 6,829,989 shares purchased and 4,728,229 shares sold with company insiders acquiring 36,873 shares on average over this time period.

To bring into focus significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated in data used to create and write this story.

Using proprietary artificial intelligence methods, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.